z-logo
open-access-imgOpen Access
Pulmonary Embolism in COVID-19 and the Unanswered Questions
Author(s) -
Anchit Bharat,
Nikita Jain,
Veerpal Singh
Publication year - 2020
Publication title -
journal of medical cases
Language(s) - English
Resource type - Journals
eISSN - 1923-4163
pISSN - 1923-4155
DOI - 10.14740/jmc3488
Subject(s) - medicine , covid-19 , pulmonary embolism , intensive care medicine , randomized controlled trial , venous thromboembolism , presentation (obstetrics) , coronavirus , disease , surgery , infectious disease (medical specialty) , thrombosis , outbreak , pathology
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has ravaged the global society as we know it. As almost a dozen pharmaceutical agents go into randomized controlled clinical trials, multiple studies have surfaced trying to associate a hypercoagulable state to coronavirus disease 2019 (COVID-19) patients. We report two COVID-19 cases who presented with occlusive pulmonary embolism (PE) strongly supporting a hypercoagulable state incurred by SARS-CoV-2. This is significant as it is one of the early reports of such an initial presentation of COVID-19 in the USA. Through our report, we invite the medical community to share a perspective about long-term management guidelines for SARS-CoV-2 associated venous thromboembolism (VTE) and prompt future research.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here